HUANG, DAVID,STEINMANN, GERHARD GUSTAV,STERN, JERRY O.
申请号：
MYPI 2011001139
公开号：
MY152824A
申请日:
2009.09.14
申请国别(地区):
MY
年份:
2014
代理人:
摘要：
THE PRESENT INVENTION RELATES TO THERAPEUTIC COMBINATIONS COMPRISING (A) COMPOUND (1), OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AS HEREIN DESCRIBED, (B) AN INTERFERON ALFA AND (C) RIBAVIRIN. COMPOUND (1) IS A SELECTIVE AND POTENT INHIBITOR OF THE HCV NS3 SERINE PROTEASE. THE PRESENT INVENTION ALSO RELATES TO METHODS OF USING SUCH THERAPEUTIC COMBINATIONS FOR TREATING HCV INFECTION OR ALLEVIATING ONE OR MORE SYMPTOMS THEREOF IN A PATIENT. (NO SUITABLE FIGURE)
